Quinidine sulfate

This page contains recent news articles, when available, and an overview of Quinidine sulfate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Quinidine sulfate
(when available)

Pharmacology and use:
Quinidine, a hydantoin anticonvulsant, is used alone or with phenobarbital or other anticonvulsants to manage tonic-clonic seizures, psychomotor seizures, neuropathic pain syndromes including diabetic neuropathy, digitalis-induced cardiac arrhythmias, and cardiac arrhythmias associated with QT-interval prolongation. For the treatment of ventricular pre-excitation and cardiac dysrhythmias

Mechanism Of Action:
Quinidine acts on sodium channels on the neuronal cell membrane, limiting the spread of seizure activity and reducing seizure propagation. The antiarrhythmic actions are mediated through effects on sodium channels in Purkinje fibers.

News Articles on Quinidine

Federal Health IT Standards Committee Seeks Physician Input  -  ‎Nov 13, 2009‎
The pharmacy had inadvertently sold the patient quinidine sulfate, a drug used to control heart arrhythmias, instead of the quinine sulfate that Bradd had ... AAFP News Now

Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com  -  ‎Nov 4, 2009‎
Its principal product candidate, Zenviatm (dextromethorphan hydrobromide/quinidine sulfate), is in phase III clinical development for the treatment of ... CNNMoney.com (press release)

Quinidine Sulfate.(Drug overview)  -  Dec 1, 2005
Quinidine is used to correct certain types of irregular heart rhythms and to slow an abnormally fast heartbeat. It is important to take only the prescribed ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

… Administrative Code - 77 Ill. Adm. Code 790.8020 QUINIDINE SULFATE...  -  Aug 10, 2005
77 Ill. Adm. Code 790.8020 QUINIDINE SULFATE (Repealed) Repealed. (Source: Repealed at 17 Ill. Reg. 15916, effective September 20, 1993) ... Pay-Per-View - Illinois Administrative Code - Loislaw

New Treatment Option for Laughing, Crying Condition in MS?  -  Apr 22, 2005
...per day for nearly a month, and was compared to a group of patients taking dextromethorphan hydrobromide alone or a group given quinidine sulfate alone. ... MS Neighborhood

Press Release: Speak with other shareholders about: (NASD: AVNR), ( …  -  Apr 19, 2007
TM) (dextromethorphan hydrobromide/quinidine sulfate ("DMQ")), an NMDA antagonist and sigma-1 agonist, in diabetic ... the trial was based on the daily ... Pay-Per-View - M2 Presswire - HighBeam Research

Idaho Administrative Code (IDAPA) - 27.01.01.185. PRODUCT …  -  Aug 9, 2005
...complex two hundred and fifty (250) mg capsules or quinidine sulfate two hundred (200) mg tablets vs. quinidine sulfate two hundred (200) mg. capsules). ... Pay-Per-View - Idaho Administrative Code - Loislaw

Investigational drug targets emotional lability.  -  Jul 25, 2005
Quinidine sulfate, a well-established antiarrhythmic agent, is used at a low dose to inhibit the CYP450 2D6 enzyme responsible for the metabolism of ... $9.94 - Drug Topics - Alacra Store

Quinine sulfate tablets.(International Pharmacopoeia)  -  Jun 22, 2007
For solution (B) use 10 mg of quinine sulfate RS per ml and for solution (C) use 10 mg of quinine sulfate RS and 10 mg of quinidine sulfate RS per ml. ... Free with registration - WHO Drug Information - AccessMyLibrary.com

Federal Register 2007 - 72 FR 62858 Lederle Laboratories et al.; …  -  Nov 7, 2007
Inc. (quinidine sulfate extended — release tablets USP) ------------------------------------------------------------------------------ NDA 14-103 ... Pay-Per-View - Federal Register 2007 - Loislaw

AVANIR Pharmaceuticals (NASDAQ:AVNR) to Release Q2 2008 Earn  -  May 2, 2008
The company's principal product candidate, Zenviatm (dextromethorphan hydrobromide/quinidine sulfate), is in Phase III clinical development for the ... TransWorldNews - TransWorldNews (press release)

Ignoring Study Design Heterogeneity in Meta-analyses—Reply  -  Oct 9, 2006
Significant heterogeneity was found only with 2 specific studies on quinidine sulfate and sotalol hydrochloride in relation to their results for mortality ... Archives of Internal Medicine

Federal Register 2007 - 72 FR 8184 Withdrawal of Approval of 128 …  -  Feb 23, 2007
CP1 Inc. ------------------------------------------------------------------------ 88P-0277/ Quinidine Sulfate 300 mg A. H. Robins CP1 ... Pay-Per-View - Federal Register 2007 - Loislaw

Missouri Regulations - 13 CSR 70-20.040 Five Prescription Limit Per …  -  Aug 16, 2005
Capsules Procyclidine Propranolol HCl Sustained Release Capsules Propranolol HCl Tablets Propylthiouracil Quinethazone Tablets Quinidine Sulfate Tablets ... Pay-Per-View - Missouri Regulations - Loislaw

cholinesterase | Definition of cholinesterase | HighBeam.com: Online ...  -  Jul 12, 2006
Journal of Medical Toxicology; March 1, 2007 ; 700+ words ... ... vitro inhibition of pseudo cholinesterase by quinidine sulfate, true cholinesterase ... Pay-Per-View - Oxford American College Dictionary - HighBeam Research

Cardiology; Class IA, IC, and III anti-arrhythmic drugs maintain...  -  Jun 7, 2006
..."Several class IA (disopyramide phosphate, quinidine sulfate), class IC (flecainide acetate, propafenone hydrochloride), and class III (amiodarone, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Stocks on the Rise.  -  Apr 19, 2007
...drug Zenvia(TM) (dextromethorphan hydrobromide/quinidine sulfate ("DMQ")), an NMDA antagonist and sigma-1 agonist, in diabetic neuropathic pain. ... Free with registration - M2 Presswire - AccessMyLibrary.com

Dextromethorphan-Quinidine Combination Reduces Inappropriate …  -  Apr 18, 2005
The investigative formulation, also known as AVP-923, consists of 30 mg each of dextromethorphan and quinidine sulfate. In a double-blind, ... Medscape

TheSUBWAY.coms Early Stock Market Alerts for Thursday, April 19,...  -  Apr 19, 2007
...drug Zenvia(TM) (dextromethorphan hydrobromide/quinidine sulfate ("DMQ")), an NMDA antagonist and sigma-1 agonist, in diabetic neuropathic pain. ... $4.95 - M2 Presswire - ECNext

Drug may help MS patients with laughing, crying spells  -  Apr 7, 2005
...received either the drug AVP-923, which is a combination of the drugs dextromethorphan hydrobromide and quinidine sulfate, or a placebo for 12 weeks. ... PsychCentral.com

AVP-923 will Help Control the Inappropriate Emotions Associated with ...  -  Apr 15, 2005
...received either the drug AVP-923, which is a combination of the drugs dextromethorphan hydrobromide and quinidine sulfate, or a placebo for 12 weeks. ... RxPG NEWS

Drug May Help MS Patients with Laughing, Crying Spells  -  Apr 1, 2005
...received either the drug AVP-923, which is a combination of the drugs dextromethorphan hydrobromide and quinidine sulfate, or a placebo for 12 weeks. ... newswise.com

Brand Names/Synonyms:
Quinidine sulfate is also known by the following brand names and/or synonymsApo-Quinidine; Biquin Durules; Cardioquin; Chinidin; Cin-Quin; Coccinine; Conchinin; Conchinine; Conquinine; Duraquin; Kinidin; Novoquinidin; Pitayin; Pitayine; Quin-Release; Quinact; Quinaglute; Quinaglute Dura-Tabs; Quinalan; Quinate; Quinatime; Quindine; Quinicardine; Quinidex; Quinidex Extentabs; Quinidine; Quinidine Gluconate; Quinidine Sulfate; Quinine, Polymers; Quinora

Drug Category:
Quinidine sulfate is categorized under the following by the FDA: Antimalarials; Antiarrhythmic Agents; Antiarrhythmic Agents; ATC:C01BA01

Dosage Forms:
SOLUTION

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
(2-ethenyl-4-azabicyclo[2.2.2]oct-5-yl)-(6-methoxyquinolin-4-yl)-methanol





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy